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Abstract
Background: The purpose of this study was to test the hypothesis that sidestream tobacco smoke extracts would 
inhibit the culture of endothelial cells and enhance platelet aggregation under diabetic vascular conditions. 
Sidestream tobacco smoke and advanced glycation end products are known cardiovascular risk factors and we aimed 
to determine the combined interaction between these two risk factors to promote cardiovascular diseases associated 
with diabetes.
Methods: Human umbilical vein endothelial cells were cultured in the presence of sidestream tobacco smoke extracts 
(SHS) or nicotine and glycated albumin (AGE) or non-glycated albumin. After 3 days, endothelial cell viability and 
density were investigated. Platelets were also incubated with these compounds for up to 6 hours. Platelet aggregation 
and the surface expression of CD41 and CD62P were examined. In some experiments, platelets were added to the 
endothelial cell culture to determine if an interaction between platelets and endothelial cells occurs that can alter the 
responses to SHS or AGE.
Results: In general, the endothelial cell culture conditions were reduced in the presence of AGE and SHS. Nicotine, did 
not play a role in this reduction. Platelet aggregation proceeded faster in the presence of AGE and SHS. Interestingly, 
with the combined culture of endothelial cells and platelets, the endothelial cell culture conditions were improved and 
the platelet functional changes were diminished in the presence of SHS and AGE, as compared with the individual 
incubations.
Conclusions: Our data suggests that diabetics that are exposed to SHS may have a higher likelihood for cardiovascular 
disease development through a diminished endothelial cell viability and an increased platelet activity, which are 
partially mediated by CD41 and not CD62P. This study provides support for an increased cardiovascular risk for diabetic 
patients that are exposed to SHS. This study also provides a new experimental technique to monitor platelet-
endothelial cell interactions.
Background
Cardiovascular diseases account for the most deaths per
year in the Western countries. The risk for cardiovascular
disease formation is highly correlated to the exposure to
environmental tobacco smoke, as either mainstream (i.e.
the smoker) or sidestream (i.e. secondhand from the
smoldering cigarette), and to the occurrence of diabetes.
In fact, the diabetic vascular system resembles that of
many cardiovascular diseases, which we believe facilitates
the formation of other cardiovascular diseases[1]. This is
predominantly due to the presence of advanced glycation
end products within the vascular system. Plasma proteins
are especially susceptible to glycation because of their rel-
atively low turn-over rate and the likelihood for sugars to
accumulate within the blood. Depending on the duration
of exposure to the sugars, the glycation extent varies,
which partially determines the effect of glycation on pro-
tein functions[2,3]. Here, we focus on developing a link
between the exposure of endothelial cells and platelets to
sidestream tobacco smoke or nicotine in the presence of
glycated albumin.
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Endothelial cells are the salient cell for many cardiovas-
cular diseases because they interact with compounds that
enter the bloodstream and partially regulate vascular per-
meability, angiogenesis and the initiation of many cardio-
vascular diseases. Platelets have a direct role in the
progression of cardiovascular diseases as well. While the
effects of cigarette smoke are multifactorial, it has been
previously shown that secondhand smoke (SHS) can
enhance tumor formation[4], vascular permeability[5]
and inflammatory responses[6], which can all lead to car-
diovascular disease formation. Nicotine, which is the pri-
mary psychoactive component of cigarettes, can enhance
the surface expression of some endothelial cell inflamma-
tory mediators[7] and can accelerate some cardiovascular
disease formation[8]. Platelet activation and aggregation
are also enhanced after exposure to secondhand
smoke[9,10], whereas nicotine strongly inhibits platelet
activation[10,11].
It has become apparent that advanced glycation end
products (AGEs) can regulate many cardiovascular dis-
ease processes through changes in endothelial cell and
platelet function. AGEs can promote monocyte migra-
tion across endothelial cells[12]. The permeability of the
endothelial cell membrane[13], the activation/functional-
ity of endothelial nitrous oxide synthase[14] and the
transformation of the endothelial cell membrane from
anti-coagulant to pro-coagulant are all regulated by the
presence of AGEs. Platelet activation, aggregation and
expression of cell surface molecules are also influenced
by the presence of advanced glycation end products[15].
In regards to both endothelial cells and platelets, the gly-
cation extent (i.e. how many glucose molecules are asso-
ciated with each albumin) has a strong role on the
measured functional changes.
In this study, we investigated the changes in platelet
activation, aggregation and cell surface marker expres-
sion in response to the combined exposure to advanced
glycation end products and sidestream tobacco smoke
extracts or nicotine. Endothelial cell culture conditions
were also investigated after exposure to advanced glyca-
tion end products and sidestream tobacco smoke extracts
or nicotine. The combined culture of endothelial cells and
platelets was used to investigate if any feedback mecha-
nisms between endothelial cells and platelets exist. We
hypothesized that the combined effects of advanced gly-
cation end products and sidestream tobacco smoke
extracts on endothelial cell or platelet function would 1)
instigate cardiovascular disease pathologies and 2) would
be more detrimental to endothelial cells and platelets as
compared to the individual exposures. Also, the addition
of pure nicotine in the presence of advanced glycation
end products would inhibit cardiovascular disease
pathologies in both endothelial cells and platelets.
Methods
Sidestream Tobacco Smoke Extraction
High tar Marlboro 100's (16 mg tar, 1.2 mg nicotine, Phil-
lip Morris) were used to make sidestream extracts as
described previously[10] with the following modifica-
tions. Puffing was mimicked by alternating the inflow
flow rate between 100 mL/min for 25 seconds to 600 mL/
min for 5 seconds. This procedure was followed until the
cigarette had burned to ~2 mm of the filter, which took
~10 minutes. Sidestream tobacco smoke was collected in
HEPES buffered saline (130 mM NaCl, 20 mM HEPES,
pH 7.4) via a step-down manifold to increase extraction
efficiency (all chemicals from Sigma-Aldrich, St. Louis,
MO unless otherwise noted). For this type of extraction,
no smoke can pass through the filter and all smoke was
collected from the smoldering end of the cigarette[10].
Albumin Glycation
Bovine serum albumin was glycated as described previ-
ously[15]. Briefly, 50 mg/mL albumin was incubated with
250 mM D-(+)-glucose, 5 mM phenylmethyl-sulfonyl-flu-
oride (PMSF, Pierce, Rockford, IL, USA), 2 mg/mL aproti-
nin, 0.5 mg/mL leupeptin,100 mg/mL penicillin and 100
U/mL streptomycin in phosphate buffered saline (PBS,
pH 7.4) at 37°C for 8 weeks. Control albumin samples
were incubated for the same time without the addition of
glucose. Timed samples were removed and dialyzed
extensively against PBS. After an 8 week exposure to glu-
cose, each albumin molecule had an average of 31 glucose
molecules associated with it[15]. Albumin samples were
aliquoted and frozen at -4°C until use.
Endothelial Cell Culture
Human umbilical vein endothelial cells (HUVECs) were
purchased from ScienCell Research Laboratories as pas-
sage one cells and were used between passages two and
five. Cells were maintained in endothelial cell growth
media supplemented with 5% fetal bovine serum, 1×
ECGS, 10 U/mL penicillin and 10 μg/mL streptomycin
(all from ScienCell) on 1% gelatin coated flasks. Non-gly-
cated albumin (BSA) or glycated serum albumin (AGE)
was added to the culture media at a final concentration of
2 mg/mL[15]. Sidestream tobacco smoke extracts were
also added to the culture conditions at a final concentra-
tion equivalent to 1 cigarette in 5 L (i.e. the approximate
plasma concentration after exposure to one cigarette). In
other experiments, nicotine was added at a final concen-
tration of 50 nM, which is the approximate nicotine con-
centration in a smokers plasma after smoking one
cigarette. HUVECs were maintained in these conditions
for 3 days. Fresh culture media was exchanged on day 1.
HUVECs were initially seeded at a density ranging from
800-1000 cells/cm2, after reaching confluence during an
earlier passage.Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
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For some conditions, the combined effects of platelets
and endothelial cells were assessed. Platelets were added
to the culture media at a concentration of 100,000/μL
(total culture media volume is 2 mL). Platelets were main-
tained in a HEPES-modified Tyrode's platelet buffer con-
sisting of 135 mM NaCl, 5 mM glucose, 2.7 mM KCl, 0.5
mM Na2HPO4, 1 mM MgCl2 1 mM trisodium citrate,
0.1% bovine serum albumin and 10 mM HEPES (pH
7.4)[10]. For cell culture experiments that included plate-
lets, culture media was exchanged daily to make sure that
the platelets were fresh within the culture (other platelet
information can be found in the Platelets section); old
media and platelets were exchanged with fresh media and
platelets. Experimental conditions were mimicked in the
new media; SHS, AGE, BSA and/or nicotine were added
at the appropriate concentration.
Endothelial Cell Cytotoxicity Assay
Cell viability and density were quantified with a cell cyto-
toxicity assay consisting of 2 μM calcein and 4 μM ethid-
ium as described previously[16,17]. Briefly, warmed
reagents were exchanged with the cell culture media on
day 3, 15 minutes prior to imaging at 37°C. After this
association time, images were only taken for ~15 minutes
at ~5-7 locations per well. Images were documented with
a Nikon TE-2000U inverted microscope interfacing with
a  C o o l s n a p  f a s t  c o o l e d  ( E S 2 )  d i g i t a l  c a m e r a  a t  1 0 ×
(Nikon, Plan Fluor DL, NA 0.3) or 20× (Nikon, Plan Fluor
ELWD, NA 0.45) objectives.
Platelets
Fresh platelet rich plasma (PRP) pheresis packs were pur-
chased from Oklahoma Blood Institute. Washed platelets
were obtained via centrifugation of PRP at 1100 × g for 9
minutes followed by a resuspension of the platelet pellet
in the HEPES-modified Tyrode's platelet buffer[10,15].
For flow cytometry studies, the washed platelet concen-
tration was adjusted to 1 × 105/μL in platelet buffer prior
to tobacco smoke/albumin incubation. For aggregation
studies, the PRP concentration was adjusted to 2.5 × 105/
μL with autologous platelet poor plasma prior to incuba-
tion. For all platelet experiments, SHS was added to plate-
lets at a concentration of 1 cigarette/5 L, nicotine was
added at 50 nM and albumin was added at 2 mg/mL.
Platelets that were not in use were kept at room tempera-
ture under gentle agitation.
Platelet Aggregation and Flow Cytometry
Timed PRP samples were warmed to 37°C in a microcu-
vette and stirred at 1000 rpm in an optical aggregometer
(Chrono-Log Model 490-2D, Havertown, PA). Platelet
aggregation was antagonized with 20 μM thrombin
receptor agonist peptide 6 (TRAP6) and the rate of aggre-
gation and the percent change of aggregation were
recorded[15]. The rate of aggregation quantifies the
speed with which platelets can participate in aggregation
whereas the percent change of aggregation quantifies
how many platelets are participating in aggregation.
Timed washed platelet samples were incubated with
PE-anti-CD41 (GPIIb) for 30 minutes at room tempera-
ture. In separate preparations, washed platelet samples
were also incubated with FITC-anti-CD62P (P-selectin)
for 30 minutes at room temperature. Platelets were
diluted 1:5 in platelet buffer and were then immediately
analyzed on a flow cytometer (Accuri C6, Ann Arbor, MI)
to quantify the surface expression of GPIIb or P-selectin.
Flow cytometry was conducted on platelet samples after
the combined incubation with endothelial cells.
Statistics/Data Analysis
Endothelial cell viability is defined as the number of live
cells (calcein positive) divided by the total number of cells
(calcein + ethidium positive cells). Endothelial cell density
is defined as the total number of live cells divided by the
image area (calibrated for each objective). This is normal-
ized by the original seeding density to provide a relative
measure of proliferation. Combined, this data provides
information regarding the toxicity of the culture condi-
tions. All data (endothelial cells and platelets) were tested
for significance using Student's paired t-test or ANOVA,
as appropriate. Tukey's post-hoc test was implemented to
determine which treatments were different, if any. All sta-
tistics were performed in the Primer for Biostatistics
(v4.0) with α = 0.05. Data was repeated for a minimum of
4 independent times, which would include different
pheresis packs for platelet experiments.
Results
Endothelial Cell Response
To test the endothelial cell response towards the com-
bined effects of secondhand smoke tobacco smoke
extracts (SHS) and glycated serum albumin, first we
investigated the individual responses to various additives
to the cell culture media. Endothelial cell viability and
density were measured after 3 days of culture for each
additive. With the addition of non-glycated albumin
(BSA), glycated albumin (AGE) or 50 nM nicotine to the
culture media, the endothelial cell culture conditions
were unaffected (Figure 1). However, with the addition of
SHS, at a concentration that would be expected to be in
blood after exposure to one smoldering cigarette, the cul-
ture conditions were significantly lower than the control
conditions. In fact, the cell viability approached 60% and
the cell density was less than 2 times that of the initial cell
seeding density. With any other additive to the culture
media, the cell density approached 15 times that of the
cell seeding density within 3 days. Therefore, the addition
of SHS to endothelial cells can drastically inhibit
endothelial cell proliferation.Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
http://www.cardiab.com/content/9/1/28
Page 4 of 12
Figure 1 HUVEC viability (A) and density (B) as a function of cell culture media additive (BSA, AGE, nicotine or SHS). Data are the mean + SEM 
of 7 independent experiments. * differs from control (ANOVA, P < 0.05).Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
http://www.cardiab.com/content/9/1/28
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To address the question posed by this study, we next
investigated the effects of SHS exposure under diabetic
vascular conditions. For these studies we added SHS (at a
concentration equal to the blood plasma level after expo-
sure to one cigarette) in addition to BSA or AGE. The
addition of pure nicotine was also investigated to deter-
mine the effect of this extract component on the cell cul-
ture conditions. With the addition of SHS to either BSA-
or AGE-supplemented media the endothelial cell viability
and the endothelial cell density were significantly reduced
as compared with the control conditions (Figure 1). In
fact, the combination of SHS and AGE further reduced
the endothelial cell viability and endothelial cell density as
compared to either of the additives alone. Again, with the
addition of pure nicotine in combination with BSA or
AGE to the cell culture media, there was no effect on the
cell culture conditions, as compared with control condi-
tions.
Platelet Response
The responses of platelets to individual incubations of
SHS, nicotine or glycated albumin have previously been
reported by us and were therefore not investigated
here[10,11,15]. Instead we investigated the combined
effects of SHS extract and glycated albumin incubation
on platelet aggregation and the surface expression of
CD41. Generally, after exposure to SHS extracts the rate
of platelet aggregation was enhanced as compared to con-
trol samples and the paired non-glycated albumin con-
trols (Figure 2A). With the addition of pure nicotine
instead of SHS extracts, there was a general attenuation
in the aggregation rate approaching that of control condi-
tions. Interestingly, the percent change of aggregation
was generally not affected by the incubation of SHS
extracts, nicotine, glycated albumin or non-glycated albu-
min (Figure 2B). Combined, the aggregation data suggests
that platelets that are exposed to SHS extracts aggregate
faster, but the quantity of platelets that participate in
aggregation remains the same, independent of the culture
additive (SHS, AGE or nicotine). Also, nicotine returns
that aggregation rate back to control levels, independent
of albumin glycation. Flow cytometry was used to con-
firm the aggregation findings and investigate a possible
mechanism for the changes in aggregation rate and per-
cent change of aggregation. In general, the trend in GPIIb
expression mimics the data found for the platelet aggre-
gation rate (Figure 3A). With the addition of SHS to the
culture media there is an enhanced surface expression of
CD41, which was attenuated with the addition of nico-
tine. We also investigated the expression of CD62P and
saw minimal changes to the expression of P-selectin, even
in the presence of SHS or nicotine (Figure 3B).
Combined Endothelial Cell and Platelet Response
In this study, our aim was to determine the combined
effects of SHS and AGE on platelets and endothelial cells.
To investigate this, we cultured endothelial cells in the
presence of platelets and measured the endothelial cell
culture response variables (cell viability and density) as
well as the surface expression of GPIIb (CD41) on the
p l a t e l e t  s u r f a c e .  I n  g e n e r a l ,  w i t h  a n y  i n c u b a t i o n  t h a t
included SHS, the endothelial cell viability and cell den-
sity was significantly reduced as compared to the control
samples (Figure 4). Interestingly, these parameters were
slightly enhanced as compared to the endothelial cell
incubation without platelets (Figure 1), suggesting that
there is some interaction between platelets and endothe-
lial cells which may act to delay cardiovascular disease
progression. As before, nicotine did not mediate any of
the changes seen here. Platelets followed a similar trend
as endothelial cells (Figure 5), where the response mea-
surement for platelets (GPIIb expression), was signifi-
cantly enhanced after exposure to SHS, but this was
generally attenuated as compared with the actions of SHS
and AGE on platelets not in the presence of endothelial
cells (Figures 3 vs. Figure 5). Combined, the endothelial
cell and platelet data suggests that when incubated
together, both the endothelial cell responses and the
p l a t e l e t  r e s p o n s e s  a r e  d i m i n i s h e d  a s  c o m p a r e d  t o  t h e
responses when the cells are not incubated together.
Discussion
In this study, we aimed to determine the combined effects
of exposure to secondhand tobacco smoke extracts and a
diabetic vascular system, induced through the presence
of advanced glycated albumin, on endothelial cells and
platelets. In previous reports, we have identified that sep-
arately, secondhand tobacco smoke extracts and glycated
albumin significantly enhance platelet susceptibility to
shear induced activation and aggregation[10,15]. Here we
started our study by investigating the endothelial cell
response to the individual incubation of secondhand
smoke extracts or glycated albumin. W e then identified
the combined responses of these factors on endothelial
cells and platelets. Finally, we investigated how these fac-
tors affect the combined culture of endothelial cells and
platelets. These factors are of interest to us because they
are common risk factors for cardiovascular disease initia-
tion/progression and it is critical to identify what effects
secondhand tobacco smoke extracts have on a pro-dia-
betic vascular system (through the presence of glycated
albumin) and if endothelial cell culture conditions and/or
platelet function change in response to this incubation.
Endothelial Cell Response
In the first series of experiments, we wanted to verify the
effects of sidestream (i.e. secondhand) tobacco smoke
extracts or glycated albumin on endothelial cells in cul-
ture. With the addition of sidestream tobacco smoke
extracts to the culture, we saw a significant reduction in
endothelial cell viability and density, which suggests that
these tobacco smoke extracts are inhibiting the normalRubenstein et al. Cardiovascular Diabetology 2010, 9:28
http://www.cardiab.com/content/9/1/28
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Figure 2 Platelet aggregation rate (A) and percent change of aggregation (B) in response to second hand tobacco smoke extracts (SHS) 
and glycated albumin (AGE). Data are the mean + SEM of 6 independent experiments. * differs from control (ANOVA, P < 0.05, paired by time). + 
differs from paired BSA (ANOVA, P < 0.05, paired by time). # differs from SHS (ANOVA, P < 0.05, paired by time).Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
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Figure 3 Surface expression of GPIIb (CD41, A) or P-selectin (CD62P, B) on the platelet membrane after the incubation of SHS or nicotine 
with AGE or BSA. Data are the mean + SEM of 4 independent experiments. * differs from incubation with BSA (t-test, P < 0.05).Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
http://www.cardiab.com/content/9/1/28
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Figure 4 HUVEC viability (A) and density (B) as a function of combined media additives in the presence of platelets (pt). Data are the mean 
+ SEM of 7 independent experiments. * differs from control (ANOVA, P < 0.05). + connected groups differ (ANOVA, P < 0.05)Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
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growth/proliferation of endothelial cells in culture (Fig-
ure 1). This is in agreement with many other studies on
sidestream smoke extracts on endothelial cells that show
an increased inflammatory response, a decreased viability
and an increased expression of cell membrane receptors,
which are common during cardiovascular diseases[18-
20]. We also confirmed that the changes in endothelial
cell culture conditions were not induced by nicotine,
which is the major psychoactive compound in tobacco
smoke. In our experiments, the addition of nicotine at a
concentration equal to the level found in a smokers blood
stream after smoking one cigarette, had no significant
effect on endothelial cell culture (Figure 1), which also
agrees with the work of others[18]. In fact, it has been
suggested that the stimulation of endothelial cell nicotinic
receptors enhances cell survival, proliferation and may
play an important role in angiogenesis[21]. Others sug-
gest that nicotine can induce cardiovascular diseases by
activating endothelial cells[7], which was not investigated
here. We also examined the effects of glycated albumin
on endothelial cell culture. There were no significant dif-
ferences between the incubation of endothelial cells with
non-glycated albumin and glycated albumin, however,
there was a general non-significant reduction in mea-
sured variables with the incubation of glycated albumin
(Figure 1). Most groups have seen slight changes in
endothelial cell function after the incubation with gly-
cated albumin, with no overall hindrance in endothelial
cell growth[22,23]. Our findings are in agreement with
these studies. Importantly, these initial experiments were
conducted to determine the base effects of sidestream
tobacco smoke extracts or glycated albumin on endothe-
lial cell culture conditions. Our data suggests that side-
stream smoke extracts (SHS) but not pure nicotine,
glycated albumin or non-glycated albumin inhibit
endothelial cell growth.
To model the effects of sidestream tobacco smoke
exposure within a diabetic vasculature, we incubated
endothelial cells with sidestream smoke extracts and gly-
cated albumin at the same time. With this combined
incubation, the endothelial cell culture conditions were
r e d u c e d  a s  c o m p a r e d  w i t h  e i t h e r  i n c u b a t i o n  b y  i t s e l f ,
Figure 5 Surface expression of GPIIb (CD41) on the platelet membrane after the combined incubation of SHS or nicotine with AGE or BSA 
in the presence of endothelial cells (EC). Data are the mean + SEM of 7 independent experiments. * differs from control (ANOVA, P < 0.05).Rubenstein et al. Cardiovascular Diabetology 2010, 9:28
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including the incubation of pure sidestream smoke (Fig-
ure 1). It was interesting to note that non-glycated albu-
min seemed to protect the detrimental effects of
sidestream smoke to some extent but it could not com-
pletely reverse these adverse effects. To the best of our
knowledge there have been no previous reports that
describe the combined effects of secondhand tobacco
smoke extracts and glycated albumin on endothelial cells.
We feel that this combined incubation is important to
study to begin to elucidate the effects of cigarette smoke
exposure (whether mainstream or sidestream) on a dia-
betic vasculature. Importantly, we saw that combining
glycated albumin and sidestream smoke extracts, the
effects on endothelial cell culture conditions were dra-
matically reduced as compared to any of the other condi-
tions investigated here and it seemed to be perpetuated
by SHS more so than AGE. We verified that this reduc-
tion was not induced by nicotine, which again had no
effect on the culture conditions of endothelial cells when
incubated with glycated albumin.
Platelet Response
The platelet response to tobacco smoke extracts, nicotine
and glycated serum albumin have been previously
reported by us[10,15]. Here, we have extended this work
by investigating the combined effects of these com-
pounds on platelet aggregation and the surface expres-
sion of CD41. As anticipated, the incubation of platelets
with secondhand smoke extracts significantly enhanced
the rate at which aggregation precedes (Figure 2). Also,
after the addition of nicotine to platelets, the aggregation
response returned back to control values. The addition of
advanced glycation end products and nicotine had mini-
mal effect on platelet aggregation. All of these findings
agrees with prior work from our group and others on the
effects of tobacco smoke extracts on aggregation[9,10].
Interestingly, the percent of aggregation was not affected
by the combined incubation of SHS extracts, nicotine or
glycated albumin. This implies that aggregation proceeds
faster but it reaches the same extent of aggregation (i.e.
the same quantity of platelets participate in aggregation).
Not many groups that we are aware of quantify aggrega-
tion in this manner, but in general we saw an enhance-
ment of the aggregation response with SHS incubation,
which has been previously reported[9]. This enhance-
ment in aggregation was at least partially mediated by an
increase in the expression of CD41 (GPIIb) as measured
by flow cytometry (Figure 3A), after exposure to SHS.
CD41 is necessary for aggregation to proceed and it
would be predicted that with an enhanced CD41 expres-
sion aggregation responses would also be enhanced. This
also agrees with previous reports that AGE incubation
can enhance CD41 expression[15]. In this study flow
cytometry measurements were conducted on platelets
that were not exposed to shear stress, whereas our previ-
ous study[15], flow cytometry was examined after a 40
minute application of shear stress at 10 dynes/cm2. We
attribute the numerical differences in our percent change
data to the shear stress application, however, the trends
are still the same; with AGE+SHS incubation, we average
a 10-20% increase in CD41 or CD62P expression. It is
well documented that shear stress activates platelets and
enhances activation markers, such as CD41. Our data
would suggest that the combined incubation of SHS and
AGE would also enhance CD41 expression, which can
potentially mediate increases in aggregation to promote
cardiovascular disease formation in vivo. In general, we
measured no changes in CD62P expression which sug-
gests that the changes we measured with aggregation
were not mediated by CD62P. This would also be antici-
pated because CD62P does not mediate aggregation,
however, in other studies[10,11], platelet activation was
enhanced after exposure to SHS. Our data suggests that
this increase in platelet activation was not mediated by
CD62P and that the majority of the changes that we mea-
sure are induced by SHS.
Combined Endothelial Cell and Platelet Response
The major goal of this study was to determine how
endothelial cells and platelets interact under diabetic vas-
cular conditions after exposure to sidestream tobacco
smoke extracts. To accomplish this, we cultured endothe-
lial cells in the presence of platelets, glycated albumin and
cigarette smoke extracts. To the best of our knowledge,
no other groups study the combined interactions of
endothelial cells and platelets in this pseudo-co-culture
system and no groups have investigated how sidestream
tobacco smoke can accelerate or decelerate cardiovascu-
lar pathologies during diabetic vascular conditions.
Under these conditions, we saw that any culture with the
addition of sidestream smoke extracts had a reduced
endothelial cell viability and cell density (Figure 4). Inter-
estingly, these reductions were somewhat attenuated as
compared to the experimental conditions without the
addition of platelets. This suggests to us that there is an
interaction between platelets and endothelial cells which
can inhibit the detrimental effects of sidestream tobacco
smoke extracts and/or glycated albumin. Again, we veri-
fied that the decrease in cell viability/density was not
mediated by nicotine. There are a few additional compar-
isons that are interesting to point out under these condi-
tions. With the addition of SHS to platelets and AGE
there was a significant reduction in endothelial cell viabil-
ity and density. This suggests that the diabetic conditions
we used may not be as detrimental to endothelial cells as
expected, but through the addition of SHS, endothelial
cells could not tolerate the diabetic vascular conditions.
Through the addition of BSA to platelets and SHS, thereRubenstein et al. Cardiovascular Diabetology 2010, 9:28
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was a significant improvement in endothelial cell viability
and density. In vivo, circulating non-glycated albumin
may act to protect endothelial cells from altered
responses. Also, by substituting between SHS and nico-
tine, in the presence of platelets and AGE, there was a sig-
nificant improvement in endothelial cell viability and
density. This suggests that nicotine is not the component
of SHS extracts that is affecting the endothelial cell cul-
ture conditions. It is important to note, that our data sug-
gests that the majority of the effects that we are seeing are
mediated by SHS and not AGEs.
Under these same culture conditions, platelets were
removed and tested for the surface expression of CD41
(GPIIb), which is necessary but not sufficient for aggrega-
t io n t o pr oc eed.  Aga in,  we  sa w  a  highe r e x pr ess ion of
CD41 in the presence of SHS extracts that were incu-
bated with any other compounds (Figure 5). Similar to
what we saw with endothelial cells, there was a slight
reduction in CD41 expression when incubated with
either BSA or nicotine. Compared to the experiments
conducted on only platelets, there was a reduction in
CD41 expression under these pseudo-co-culture condi-
tions. This again suggests to us, that there is some feed-
back mechanism between endothelial cells and platelets
which helps to minimize pro-cardiovascular disease
pathologies. Again, SHS seems to dominate the changes
that we are measuring. We were unable to examine plate-
let functional changes (i.e. platelet aggregation rates)
because endothelial cells could not be cultured in the
presence of platelet poor plasma and this is required for
optical platelet aggregation studies. We are however, opti-
mizing this experimental technique to quantify other
platelet functional changes.
Conclusions
It has previously been reported that tobacco smoke and
glycated plasma proteins are associated with an enhanced
cardiovascular risk. Here we wanted to investigate the
combined effects of SHS extracts and glycated albumin to
determine whether or not a diabetic who is exposed to
tobacco smoke would have an increased likelihood for the
development of cardiovascular diseases. We have seen
that after exposure to SHS and AGE, endothelial cells and
platelets have a reduced viability/density and a higher
likelihood to activate, respectively. This reduced viability
and increased aggregation potential was generally height-
ened as compared with the exposure to either compound
(SHS or AGE) individually. Also, with addition of nicotine
to either endothelial cells or platelets, the harmful
responses were attenuated. Interestingly, when platelets
and endothelial cells were cultured together, the reduc-
tion in endothelial cell viability and enhancement in
aggregation potential, as mediated by changes in CD41
expression, were also attenuated as compared with the
individual cell exposure. This would suggest that there is
a platelet-endothelial cell feedback mechanism that pre-
vents, to some extent, cardiovascular disease pathologies.
However, this pathway has not been identified here,
although we have shown that CD41 is partially responsi-
ble for the changes that we quantified and CD62P is not
responsible for the measured changes. In this work, we
have revealed that the combined incubation of SHS and
AGE is more potent than the sole incubation of either of
these cardiovascular risk factors and this combined incu-
bation may facilitate cardiovascular disease development
through a decreased endothelial cell viability/density and
an enhancement of the hemostatic system.
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